Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus‐based therapy: a multivariate analysis of results at five years1
- 16 March 2007
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 21 (3), 330-336
- https://doi.org/10.1111/j.1399-0012.2007.00645.x
Abstract
Changes in calculated glomerular filtration rate (GFR) from baseline to five yr were analyzed in relation to risk factors among renal transplant recipients. At three months after transplantation (baseline), 430 eligible patients receiving sirolimus (SRL), cyclosporine (CsA), and steroids (ST) were randomly assigned (1:1) to continue SRL–CsA–ST or have CsA withdrawn and SRL trough levels increased (SRL–ST group). For each risk factor, changes from baseline were compared within each treatment using a t‐test and between treatments using ANCOVA. Univariate then multivariate robust linear regression analyses were also performed. In the SRL–ST group, changes from baseline were not significantly different for any risk factor. With the exception of cold ischemia time >24 h, GFR values declined significantly for all risk factors in SRL–CsA–ST patients. For all risk factors, except second transplant or cold ischemia time >24 h, renal function was significantly different between groups. By order of significance in the multivariate analysis, treatment (p < 0.001), donor age (p < 0.001), proteinuria (p < 0.001), and biopsy‐confirmed rejection (p = 0.010) were significant predictors of GFR change from baseline. In conclusion, patients with risk factors for reduced renal function benefit from SRL maintenance therapy without CsA vs. those remaining on CsA.Keywords
This publication has 18 references indexed in Scilit:
- Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized TrialsTransplantation, 2006
- Early Low‐Grade Proteinuria: Causes, Short‐Term Evolution and Long‐Term Consequences in Renal TransplantationAmerican Journal of Transplantation, 2005
- CD31+ Naïve Th Cells Are Stable during Six Months Following Kidney Transplantation: Implications for Post-transplant Thymic FunctionAmerican Journal of Transplantation, 2005
- Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantationTransplant International, 2004
- Predictors of Success in Conversion from Calcineurin Inhibitor to Sirolimus in Chronic Allograft DysfunctionAmerican Journal of Transplantation, 2004
- Long-Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?American Journal of Transplantation, 2004
- Post-transplant renal function in the first year predicts long-term kidney transplant survivalKidney International, 2002
- SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10Transplantation, 2001
- PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- ARGINASE RELEASE FOLLOWING LIVER REPERFUSION EVIDENCE OF HEMODYNAMIC ACTION OF ARGINASE INFUSIONSTransplantation, 1995